Drugs Current Affairs - 2020
The Lifeline UDAN was launched by the Ministry of Civil Aviation to help India fight against COVID-19. Under this initiative, flights were operated in transporting essential equipment and medicines all over the country.
The Lifeline UDAN initiative was a huge success as in just 5 days of its launch, more than 15.4 tonnes of essential supplies have been transported in 62 aircrafts. The products transported included masks and gloves, consumables, etc. In order help public to track Lifeline Udan flights, the status of the flights were uploaded in a portal. The portal was developed by National Informatics Centre.
The initiative provided a special focus to the north-eastern region and to the Ladakh region. For the ease of flight operation, the flight hubs were set up in Delhi, Mumbai, Kolkata, Hyderabad and Bengaluru.
The UDAN initiative focused on the regional airport development. It aimed to make air travel widespread and affordable.
Tags: COVID-19 • Drugs • Essential Drugs • Essential Medicines • Ladakh
Bharat Biotech along with virologists of University of Wisconsin and Madison have begun development and testing of a new vaccine called CoroFlu for COVID-19.
The vaccine is to be developed with the M2SR vaccine as the main component. The M2SR vaccine is used against flu. The M2SR is a self-limiting version of the influenza virus. It induces immune response against flu.
The gene sequences of SARS-CoV-2 that causes the COVID-19 disease is to be inserted into the M2SR. This will induce immunity against corona virus. The process is expected to take three to six months. The vaccine will be delivered intranasally.
The Bharat Biotech is to manufacture around 300 million doses of the vaccine. The doses are to be distributed all over the world.
Bharat Biotech is an Indian Biotechnology company. It is headquartered at Hyderabad. It was founded by Krishna Ella, an Indian Scientist. It is the first bio-pharma company audited and approved by the Korean Food and Drugs Administration, Hyderabad.
Tags: Biotechnology • Corona Virus • COVID-19 • Department of Biotechnology (DBT) • Drugs